Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Veracyte Snaps Up Decipher Biosciences, Inc.

Veracyte Snaps Up Decipher Biosciences, Inc.

Veracyte, Inc. (NASDAQ: VCYT), the South San Francisco, California-based diagnostics company, has bought Decipher Biosciences, Inc for $600 million consisting of $250 million in cash and up to $350 million in stock. Decipher Biosciences is a commercial-stage precision oncology company focused on urologic cancers. It has a comprehensive portfolio of tests which leverage whole transcriptome analysis and proprietary machine learning algorithms to improve patient decision-making across the clinical care continuum. This acquisition solidifies Veracyte’s global position in the genomic cancer diagnostics market while accelerating revenue growth. Collectively, Decipher’s genomic tests have... Read More »
Healthcare Services Bankruptcies Spiked in 2020

Healthcare Services Bankruptcies Spiked in 2020

Even before the Covid-19 pandemic arrived in the United States early in 2020, observers expected the flow of healthcare services bankruptcies filings by small rural hospitals and other service organizations stressed by regulatory and reimbursement challenges to continue at a steady trickle. Once the economic and social shutdowns began in mid-March, hospitals were forced to suspend elective procedures, emergency room visits plummeted, physician practices largely closed temporarily and home health agencies experienced a wave of visit cancellations. The cost of personal protective equipment, a requirement for healthcare workers, soared to astronomical highs. Of course, merger and acquisition... Read More »
MB2 Dental Solutions Finds a New Partner

MB2 Dental Solutions Finds a New Partner

After Sentinel Capital Partners took a majority interest in MB2 Dental Solutions (MB2), the dental services organization became a prolific buyer in the healthcare M&A market, building a national network of practices. The organization has a presence in 24 states and has partnered with more than 275 dental practices. In 2019, MB2 had an estimated revenue of $320 million.  Now that partnership has ended. Sentinel Capital Partners is exiting its investment and Charlesbank Capital Partners will become the new majority owner. Charlesbank Capital Partners is a middle-market private investment firm managing more than $7 billion of capital. Charlesbank focuses on management-led buyouts and... Read More »
MultiPlan Corporation Acquires Discovery Health Partners

MultiPlan Corporation Acquires Discovery Health Partners

MultiPlan Corporation (NYSE: MPLN), a leading value-add provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, is wasting no time in expanding. If the name rings a bell, it’s because MultiPlan just went public in July 2020 in an $11 billion reverse merger with Churchill Capital Corp III, a special purpose acquisition company (SPAC). It was one of the biggest deals of 2020, and one of many in healthcare involving a reverse merger with a SPAC. Since MultiPlan went public, the company has announced two transactions under its “Enhance-Extend-Expand strategy,” including the most recent one for Discovery Health Partners, valued at... Read More »
Horizon Therapeutics Acquires Viela Bio

Horizon Therapeutics Acquires Viela Bio

Horizon Therapeutics plc (NASDAQ: HZNP) has been a major player in the healthcare M&A market for the last few years. According to search results in our Healthcare Deal Database, the company last reported a deal in April 2020, acquiring Curzion Pharmaceuticals, Inc., a San Diego-based biotechnology firm developing treatments for rare fibrotic diseases, for a modest $45 million. However, Horizon Therapeutics is back with a new deal, buying Viela Bio, Inc. in a $3.05 billion deal.  Viela Bio is a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. The company has a substantial pipeline... Read More »
Hill-Rom Holdings Hits the Ground Running

Hill-Rom Holdings Hits the Ground Running

Only a month into the new year and Hill-Rom Holdings, Inc. (NYSE: HRC) already has two acquisitions on the books, according to search results in our Healthcare Deal Database. Hill-Rom Holdings operates as a medical technology company worldwide. Its products enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home.  Back on January 19, the medical device company acquired Bardy Diagnostics, Inc. for $375 million in cash, plus net operating losses valued at more than $20 million. Bardy Diagnostics was founded in 2013 and helps improve clinical management and outcomes for... Read More »
Health Care M&A Deals, January 29, 2021

Health Care M&A Deals, January 29, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week by disclosed price is Cofinimmo’s acquisition of a portfolio of six care homes and one post-acute/rehab center in Ireland with 491 beds for $112.9 million. Six of the seven sites are located within the province of Leinster, including five within the Greater Dublin region. The final site of Castlemanor is in the province of... Read More »
Health Care M&A Deals, January 29, 2021

Health Care M&A Deals, January 22, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of last week was Boston Scientific Corporation’s acquisition of Preventice Solutions, Inc. for $925 million. Preventice Solutions offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors to cardiac event monitors and mobile cardiac telemetry. The company recorded net sales of $158 million in 2020, a... Read More »
Thermo Fisher Acquires Henogen S.A.

Thermo Fisher Acquires Henogen S.A.

After a surprise collapse of its takeover bid for QIAGEN N.V. (NYSE: QGEN), Thermo Fisher Scientific Inc. (NYSE: TMO) is back with a new deal in 2021. Thermo Fisher is buying Henogen S.A. from Groupe Novasep SAS for approximately EUR 725 million ($877.5 million) in cash. Based in Belgium, Henogen S.A. is a viral vector manufacturing business that provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers.  Groupe Novasep partners with a variety of industries to provide technically optimized and economical solutions for the life science industry.  Henogen has two facilities and approximately 400 employees with substantial... Read More »
HCA Healthcare Adds Meadows Regional Medical Center

HCA Healthcare Adds Meadows Regional Medical Center

The Hospital market is off to a strong start in 2021, with seven deals on the books in January. The health system giant, HCA Healthcare (NYSE: HCA), just announced the largest deal in the sector by price. HCA purchased Meadows Regional Medical Center, a 52-bed community hospital in Vidalia, Georgia from Meadow Health Alliance, Inc. for $73 million. A letter of intent was filed in September 2019, and the Toombs County Hospital Authority and Meadow Health Alliance have approved the sale.  Meadow Health Alliance generated $153.6 million in revenue in 2019 and estimated $9.63 million EBITDA. Meadows Regional will be HCA’s 10th hospital in Georgia. This deal is expected to close on or before... Read More »